- Exchange: London
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
GlaxoSmithKline PLC
+ Add to WatchlistGSK:LN
1,574.000 GBp 27.500 1.78%As of 11:14:43 ET on 10/03/2013.
Snapshot for GlaxoSmithKline PLC (GSK)
| Open: | 1,548.000 | Day's Range: | 1,548.000 - 1,575.500 | Volume: | 5,481,053 |
|---|---|---|---|---|---|
| Previous Close: | 1,546.500 | 52wk Range: | 1,314.000 - 1,816.000 | 1-Yr Rtn: | +14.13% |
Key Statistics for GSK
| Current P/E Ratio (ttm) | 19.0916 |
|---|---|
| Estimated P/E(12/2013) | 13.5919 |
| Relative P/E vs. UKX | 0.9811 |
| Earnings Per Share (GBP) (ttm) | 0.8216 |
| Est. EPS (GBP) (12/2013) | 1.1540 |
| Est. PEG Ratio | 1.9103 |
| Market Cap (M GBP) | 76,588.43 |
| Shares Outstanding (M) | 4,882.91 |
| 30 Day Average Volume | 7,101,168 |
| Price/Book (mrq) | 11.9009 |
| Price/Sale (ttm) | 2.8957 |
| Dividend Indicated Gross Yield | 5.38% |
| Cash Dividend (GBp) | 18.0000 |
| Dividend Ex-Date | 08/07/2013 |
| 5 Year Dividend Growth | 6.68% |
| Next Earnings Announcement | 10/23/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GSK
Company Profile & Key Executives for GSK
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
| Andrew WittyChief Executive Officer | Simon P DingemansChief Financial Officer |
| David RedfernChief Strategy Officer | Moncef SlaouiChairman:R&D & Vaccines |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
Advertisement
-
GSK News
-
Industry News
Advertisement
Sponsored Links
Advertisements
Rate this Page